Study for comparison of bupivacaine alone bupivacaine plus dexmedetomidine and bupivacaine plus magnesium sulfate for prevention of shivering after spinal anaesthesia in prostate surgery.
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2021/01/030305
- Lead Sponsor
- Dr SN Medical college and associated group of hospitals Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Male patients of ASA grade I and II of age 18-60 years posted for transurethral resection of prostate suitable for administration of regional anaesthesia
Exclusion Criteria
Patients refusal, BMI >28.0, spinal abnormality, patients with CKD, any contraindication to spinal anaesthesia like sepsis, abnormal coagulation profile, emergency surgery, infection at site of injection, allergy to local anaesthetics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of intrathecal bupivacaine alone, bupivacaine plus dexmedetomidine and bupivacaine plus magnesium sulfate group in terms of incidence and intensity of shiveringTimepoint: 3 Months
- Secondary Outcome Measures
Name Time Method To compare the safety of intrathecal bupivacaine alone, bupivacaine plus dexmedetomidine and bupivacaine plus magnesium sulfate group in terms of hypothermia sedation score and complication including hypotension, bradycardia, nausea, vomiting and total dose of pethidine required to control shiveringTimepoint: 3 months